1. Maron MS, Olivotto I, Betocchi S, Casey, SA, Lesser JR, Losi MA, Cecchi F, Maron BJ. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 2003;348:295-303.
2. Maron MS, Olivotto I, Zenovich AG, Udelson JE, Link MS, Pandian NG, Kuvin  JT, Nistri S, Cecchi F, Maron BJ. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation. 2006; 114:2232-2239
3. Maron BJ. Thompson PD. Ackerman MJ. Balady G. Berger S. Cohen D. Dimeff R. Douglas PS. Glover DW. Hutter AM Jr. Krauss MD. Maron MS. Mitten MJ.  Roberts WO. Puffer JC. American Heart Association Council on Nutrition, Physical Activity, and Metabolism. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation. 2007;115(12):1643-455.
4. Adabag SA, Maron BJ, Appelbaum E, Harrigan C, Gibson CM, Buros JL, Lesser JR, Hanna CA, Udelson JE, Manning WJ, Maron MS. Occurrence and Frequency of Arrhythmias in Hypertrophic Cardiomyopathy in Relation to Delayed  Enhancement on Cardiovascular Magnetic Resonance. J Am Coll Cardiol. 2008;51:1369-1374.
5. Maron MS, Finley JJ, Bos JM, Hauser RH, Manning WJ, Haas TS, Lesser JR, Udelson JE, Ackerman MJ, Maron BJ. Prevalence, clinical significance and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy. Circulation; 118:1541-1549

Honors and Awards:

Professional Affiliations:

Foreign Languages:

Gender:

M